Fabio Palombo

Fabio Palombo

Company: NeoMatrix

Job title: Chief scientific officer


Improved Feasibility & Efficacy of Synthetic DNA for Personalized Cancer Vaccines 3:00 pm

Reviewing key features that make neoantigen anti-cancer vaccines attractive such as their ability to stimulate an immune response that targets the patient’s specific tumor Why personalized neoantigen vaccines have the potential to be more targeted and less toxic compared to traditional cancer treatments, which can often have harmful side effects and are not always effective…Read more

day: Pre-Conference Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.